Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bausch + Lomb Corporation Common Shares
(NY:
BLCO
)
17.79
-0.15 (-0.84%)
Streaming Delayed Price
Updated: 10:32 AM EST, Feb 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
31,295
Open
18.06
Bid (Size)
17.75 (200)
Ask (Size)
17.81 (200)
Prev. Close
17.94
Today's Range
17.63 - 18.06
52wk Range
10.45 - 18.12
Shares Outstanding
353,800,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BLCO Q4 2025 Deep Dive: Dry Eye and Product Innovation Propel Growth, Margin Expansion in Focus
February 19, 2026
Eyecare company Bausch + Lomb (NYSE:BLCO) announced better-than-expected revenue in Q4 CY2025, with sales up 9.8% year on year to $1.41 billion. The company’s full-year revenue guidance of $5.43...
Via
StockStory
Bausch + Lomb Corp (NYSE:BLCO) Reports Mixed Q4 2025 Results: Revenue Beat, EPS Miss
↗
February 18, 2026
Via
Chartmill
Performance
YTD
+7.3%
+7.3%
1 Month
+4.8%
+4.8%
3 Month
+15.1%
+15.1%
6 Month
+22.4%
+22.4%
1 Year
+12.5%
+12.5%
More News
Read More
Bausch + Lomb’s (NYSE:BLCO) Q4 CY2025: Beats On Revenue
February 18, 2026
Via
StockStory
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
February 18, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb (BLCO) Q4 Earnings: What To Expect
February 16, 2026
Via
StockStory
Topics
World Trade
3 Reasons to Sell BLCO and 1 Stock to Buy Instead
February 09, 2026
Via
StockStory
Topics
Bankruptcy
Stocks
1 Healthcare Stock to Research Further and 2 Facing Headwinds
January 29, 2026
Via
StockStory
Topics
Stocks
3 Stocks Under $50 That Fall Short
January 26, 2026
Via
StockStory
3 Cash-Burning Stocks We’re Skeptical Of
January 22, 2026
Via
StockStory
Topics
Bankruptcy
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18
January 20, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.
January 05, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Completes Refinancing of Outstanding Term B Loans
January 02, 2026
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
1 Profitable Stock to Keep an Eye On and 2 We Question
December 17, 2025
Via
StockStory
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year
↗
December 17, 2025
Via
The Motley Fool
Bausch + Lomb Announces Two Board of Directors Appointments
December 17, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
December 12, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
Why Bausch + Lomb (BLCO) Stock Is Trading Up Today
December 11, 2025
Via
StockStory
Topics
Artificial Intelligence
Initial Public Offering
3 Healthcare Stocks We Think Twice About
December 10, 2025
Via
StockStory
Topics
Stocks
BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point?
↗
December 03, 2025
Via
The Motley Fool
Topics
Initial Public Offering
Regulatory Compliance
Why Bausch + Lomb (BLCO) Stock Is Up Today
December 02, 2025
Via
StockStory
Topics
Economy
Initial Public Offering
3 Small-Cap Stocks with Warning Signs
December 01, 2025
Via
StockStory
3 Cash-Burning Stocks We Approach with Caution
November 23, 2025
Via
StockStory
Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know
November 21, 2025
Via
StockStory
Topics
Economy
Bausch + Lomb to Participate in Citi Global Healthcare Conference
November 18, 2025
From
Bausch + Lomb Corporation
Via
Business Wire
Frequently Asked Questions
Is Bausch + Lomb Corporation Common Shares publicly traded?
Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
What exchange does Bausch + Lomb Corporation Common Shares trade on?
Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
What is the current price of Bausch + Lomb Corporation Common Shares?
The current price of Bausch + Lomb Corporation Common Shares is 17.79
When was Bausch + Lomb Corporation Common Shares last traded?
The last trade of Bausch + Lomb Corporation Common Shares was at 02/23/26 10:32 AM ET
What is the market capitalization of Bausch + Lomb Corporation Common Shares?
The market capitalization of Bausch + Lomb Corporation Common Shares is 6.29B
How many shares of Bausch + Lomb Corporation Common Shares are outstanding?
Bausch + Lomb Corporation Common Shares has 6B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
